ABBV was trading lower on friday after the the FDA pushed back the review period for the company's supplemental marketing application for upadacitinib in active psoriatic arthritis. Despite the big drop, it fell right to key support (right at the bottom of a range) making a good entry here in terms of RR, having a tight stop and aiming for the top of range (gap fill). For options, look for leaps.
Trade attivo
Added a swing position at open, looks great so far.
Trade chiuso: obiettivo raggiunto
trimmed most of my position here and only have runner left. great profits!
Autopsy of my trades. Admin of SimbaStocks. Not a registered financial advisor, all related content are my opinions and solely my opinions.
Anche su:
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.